European Pharma Pushes Back Against ‘Discriminatory’ New EU Drug Pollution Proposals
European Commission Insists Its Measures Against Pharmaceutical Pollution Have Wide Support
Medicines for Europe, along with EFPIA and the AESGP, say that the ‘polluter pays’ principle behind proposed new European rules on wastewater treatment would saddle pharmaceutical manufacturers with costs that “jeopardize patient access.”
